Moffitt Cancer Center

Investors

Moffitt Cancer Center

 

 

Located in Tampa, Moffitt Cancer Center is one of only 45 National Cancer Institute-designated Comprehensive Cancer Centers, a distinction that recognizes Moffitt’s excellence in research, as well as its contributions to clinical trials, prevention, and cancer control. The third largest cancer treatment facility in the U.S., Moffitt Cancer Center is the #1 cancer hospital in Florida and has been listed in U.S. News & World Report as one of “America’s Best Hospitals” for cancer since 1999. With more than 5,200 employees, Moffitt Cancer Center has an economic impact on the state of more than $2.1 billion.

...

Alan F. List, M.D., President and CEO

Dr. Alan F. List is the President and CEO of Moffitt Cancer Center. He is internationally recognized for his many contributions in the development of novel, more effective treatment strategies for myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML). His pioneering work led to the development of lenalidomide (Revlimid®) from the laboratory to clinical trials, which went on to receive fast-track designation from the U.S. Food and Drug Administration and approval for the treatment of patients with MDS and multiple myeloma. This work transformed the natural history of MDS from a premalignant condition that progressed to malignancy requiring aggressive treatment to a condition managed in the outpatient setting with oral agents. Prior to his current position, Dr. List served as Executive Vice President and Physician-in-Chief, the Vice Deputy Physician-in-Chief and the Chief of the Malignant Hematology Division at Moffitt, where he also holds the Morsani Endowed Chair.

Investors

Moffitt Cancer Center

 

 

Located in Tampa, Moffitt Cancer Center is one of only 45 National Cancer Institute-designated Comprehensive Cancer Centers, a distinction that recognizes Moffitt’s excellence in research, as well as its contributions to clinical trials, prevention, and cancer control. The third largest cancer treatment facility in the U.S., Moffitt Cancer Center is the #1 cancer hospital in Florida and has been listed in U.S. News & World Report as one of “America’s Best Hospitals” for cancer since 1999. With more than 5,200 employees, Moffitt Cancer Center has an economic impact on the state of more than $2.1 billion.

...
...

Alan F. List, M.D., President and CEO

Dr. Alan F. List is the President and CEO of Moffitt Cancer Center. He is internationally recognized for his many contributions in the development of novel, more effective treatment strategies for myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML). His pioneering work led to the development of lenalidomide (Revlimid®) from the laboratory to clinical trials, which went on to receive fast-track designation from the U.S. Food and Drug Administration and approval for the treatment of patients with MDS and multiple myeloma. This work transformed the natural history of MDS from a premalignant condition that progressed to malignancy requiring aggressive treatment to a condition managed in the outpatient setting with oral agents. Prior to his current position, Dr. List served as Executive Vice President and Physician-in-Chief, the Vice Deputy Physician-in-Chief and the Chief of the Malignant Hematology Division at Moffitt, where he also holds the Morsani Endowed Chair.